Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

Rhea-AI Summary

Optinose (NASDAQ: OPTN), a pharmaceutical company specializing in treatments for ENT and allergy patients, will present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ.

The presentation, scheduled for May 20, 2024, at 11:30 a.m. ET, will feature a company overview and business update from Optinose's management team.

The live presentation will be webcast, and a replay will be available for 30 days on the Optinose website.

Positive

• Scheduled presentation at a prestigious investor conference, potentially increasing visibility.
• Live webcast availability broadens access to the presentation.
• Replay of the webcast available for 30 days, ensuring prolonged engagement.

Negative

• The PR provides no new substantial financial or clinical data.
• The announcement lacks specific details on new business developments or milestones.

YARDLEY, Pa., May 17, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ on May 20, 2024 at 11:30 a.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.

Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531

FAQ

What is the significance of Optinose presenting at the H.C. Wainwright 2nd Annual BioConnect Investor Conference?

Presenting at the conference can increase Optinose's visibility among investors and provide updates on its business.

When will Optinose present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference?

Optinose will present on May 20, 2024, at 11:30 a.m. ET.

How can I watch the Optinose presentation at the BioConnect Investor Conference?

The presentation will be webcast live on the Optinose website's Investors page, with a replay available for 30 days.

What will Optinose discuss at the H.C. Wainwright 2nd Annual BioConnect Investor Conference?

Optinose management will provide a company overview and business update.

What is the stock symbol for Optinose?

The stock symbol for Optinose is OPTN.